DOXEPIN
Total Payments
$280,614
Transactions
5
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $280,614 | 5 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $280,614 | 5 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Randomized, Open-Label, 2-way Crossover Bioequivalence Study of Doxepin Cream, 5 Manufactured by Amneal Pharmaceuticals LLC and Zonalon Doxepin Cream, 5 Marked by Bioglan Phamra Inc. Following a 3-Gram Dose to Healthy Subjects 172005 | Amneal Pharmaceuticals LLC | $280,614 | 0 |
Top Doctors Receiving Payments for DOXEPIN
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | St. Petersburg, FL | $280,614 | 5 |
Ad
Manufacturing Companies
- Amneal Pharmaceuticals LLC $280,614
Product Information
- Type Drug
- Total Payments $280,614
- Total Doctors 0
- Transactions 5
About DOXEPIN
DOXEPIN is a drug associated with $280,614 in payments to 0 healthcare providers, recorded across 5 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.
Payment data is available from 2018 to 2018. In 2018, $280,614 was paid across 5 transactions to 0 doctors.
The most common payment nature for DOXEPIN is "Unspecified" ($280,614, 100.0% of total).
DOXEPIN is associated with 1 research study, including "Randomized, Open-Label, 2-way Crossover Bioequivalence Study of Doxepin Cream, 5 Manufactured by Amneal Pharmaceuticals LLC and Zonalon Doxepin Cream, 5 Marked by Bioglan Phamra Inc. Following a 3-Gram Dose to Healthy Subjects 172005" ($280,614).